Profil
Robin Ali is currently a Professor at UCL Institute of Ophthalmology.
Previously, he held the position of Head-Preclinical Ophthalmology at MeiraGTx Holdings Plc and served as the President of the European Society of Gene & Cell Therapy.
He obtained his undergraduate degree from University College London in 1988 and his doctorate degree from the same institution in 1993.
Postes actifs de Robin Ali
| Sociétés | Poste | Début |
|---|---|---|
UCL Institute of Ophthalmology
UCL Institute of Ophthalmology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Robin Ali
| Sociétés | Poste | Fin |
|---|---|---|
European Society of Gene & Cell Therapy | President | 28/10/2024 |
| MEIRAGTX HOLDINGS PLC | Corporate Officer/Principal | - |
Formation de Robin Ali
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Society of Gene & Cell Therapy | |
UCL Institute of Ophthalmology
UCL Institute of Ophthalmology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MeiraGTx Holdings Plc
MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
















